Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Meeting

---
identifier: "/us/fr/2011-5626"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2011-5626"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Meeting"
positive_law: false
currency: "2011-03-11"
last_updated: "2011-03-11"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-5626"
document_type: "notice"
publication_date: "2011-03-11"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "76 FR 13413"
fr_volume: 76
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Meeting

Studies at the Animal-Human Interface of Influenza and Other Zoonotic Diseases in Vietnam, Funding Opportunity Announcement (FOA) IP11-005; The Incidence and Etiology of Influenza-Associated Community-Acquired Pneumonia in Hospitalized Persons Study, FOA IP11-011; Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection  Among Children and Adults in India, FOA IP11-012; Influenza Vaccine Efficacy in Tropical and Developing Countries, FOA IP11-013; and Influenza and Other Respiratory Diseases in Southern Hemisphere, FOA IP11-014; initial review.

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

*Time and Date:* 8 a.m.-5 p. m., May 12, 2011 (Closed).

*Place:* Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997-1100.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the initial review, discussion, and evaluation of applications received in response to “Studies at the Animal-Human Interface of Influenza and Other Zoonotic Diseases in Vietnam, FOA IP11-005; The Incidence and Etiology of Influenza-Associated Community-Acquired Pneumonia in Hospitalized Persons Study, FOA IP11-011; Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India, FOA IP11-012; Influenza Vaccine Efficacy in Tropical and Developing Countries, FOA IP11-013; and Influenza and Other Respiratory Diseases in Southern Hemisphere, FOA IP11-014, initial review.”

*Contact Person for More Information:* Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498-2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: March 7, 2011.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.